dipyridamole and Leukemia, Lymphoid
dipyridamole has been researched along with Leukemia, Lymphoid in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Dipyridamole use was related to a lower risk of lymphoid neoplasms, indicating a clinical potential of dipyridamole to be an adjunct anti-tumour agent against lymphoid neoplasms." | 1.72 | Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. ( Huang, W; Ji, J; Sundquist, J; Sundquist, K, 2022) |
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Huang, W | 1 |
Sundquist, K | 1 |
Sundquist, J | 1 |
Ji, J | 1 |
Edwards, NL | 1 |
Recker, D | 1 |
Manfredi, J | 1 |
Rembecki, R | 1 |
Fox, IH | 1 |
Ullman, B | 1 |
Coons, T | 1 |
Rockwell, S | 1 |
McCartan, K | 1 |
Hirose, M | 1 |
Takeda, E | 1 |
Ninomiya, T | 1 |
Kuroda, Y | 1 |
Miyao, M | 1 |
Other Studies
4 other studies available for dipyridamole and Leukemia, Lymphoid
Article | Year |
---|---|
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Chemoprevention; Comorbidity; Dipyridamole; Disease Susceptibility | 2022 |
Regulation of purine metabolism by plasma membrane and cytoplasmic 5'-nucleotidases.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; B-Lymphocytes; Cell Line; Cell Membrane; Cytoplasm; Dipyrida | 1982 |
Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Topics: Acquired Immunodeficiency Syndrome; Biological Transport; Cell Division; Cell Survival; Deoxycytidin | 1988 |
Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Dipyridamole; Dose-Response Relati | 1987 |